Press release
Protagen and Charles River form strategic partnership
Dortmund, Germany, October 28, 2011. Protagen AG, Dortmund, a GMP-certified specialist in the characterization of protein drugs and Charles River Laboratories International, Inc., one of the world leading companies in high-quality research models and preclinical and clinical support services, are pleased to announce a strategic Marketing & Sales alliance.For Charles River Biopharmaceutical Services (BPS) the fast-growing demand for biopharmaceuticals testing requires an expert partner with a broad range of services. Charles River BPS delivers client-focused solutions tailored to the specific testing and manufacturing requirements of biologics. Partnering with Protagen AG, an international leading specialist in the fields of in-vitro diagnostics and GMP-compliant protein analysis, will provide clients with services covering the entire range of protein analytics from detailed protein characterization to stability and lot release testing.
Working together, Charles River and Protagen can offer analytical experience and superior services through a single point of contact, providing more efficient project work and study design.
“The technology portfolio and the exceptional expertise of Charles River in the area of certified bioservices will synergistically complement the experience and competences of Protagen in the field of biotherapeutics and biosimilars. The customers in the pharmaceutical and biotech sector will profit from this alliance through the direct access to a comprehensive service portfolio “, comments Dr. Stefan Müllner, CEO of Protagen AG.
About Protagen AG
Protagen AG (http://www.protagen.com) is an international leading specialist in the fields of in-vitro diagnostics and GMP-compliant protein analysis. The innovations of Protagen are UNIarray®, a technology platform for the development of novel serum based diagnostics, as well as UNIchip®, a versatile product family of protein microarrays for faster development of antibodies.
Contact
Dr. Stefan Müllner
CEO
Protagen AG
Otto-Hahn-Str. 15
44227 Dortmund
Tel: +49 (0) 231 9742 6300
Fax: +49 (0) 231 9742 6301
E-Mail: info@protagen.de
Media Enquiries
Bettina Franz
Protagen AG
Otto-Hahn-Str. 15
44227 Dortmund
Tel: +49 (0) 231 9742 6300
Fax: +49 (0) 231 9742 6301
E-Mail: bettina.franz@protagen.de
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Protagen and Charles River form strategic partnership here
News-ID: 198484 • Views: …
More Releases from Protagen AG
Protagen and OncoTyrol form strategic alliance to validate the UNIarray® techno …
Dortmund, Germany and New Jersey, USA, June 10, 2009. Protagen AG and the Medical University Innsbruck, Department of Urology, have recently identified autoantigen candidates present in serum of patients with prostate cancer using the proprietary UNIArray® technology platform. In Europe, prostate cancer is the second most frequent lethal malignancy in men. Yearly about 40,000 men die of prostate cancer in the European Union.
Current standard of screening for prostate…
Protagen meets with FDA
Dortmund, Germany and New Jersey, USA, February 19, 2009. Protagen AG, a leading provider of GMP compliant protein analytical services, protein bioinformatics, and protein biochips announces that it participated in two meetings with FDA personnel during the week of January 26, 2009. The meetings were intended to provide a detailed introduction to the company’s UNIarray® technology position and its potential use in the development of novel diagnostics for multiple sclerosis…
Bayer HealthCare and Protagen sign a contract to evaluate the UNIarray® technol …
Dortmund, Germany and New Jersey, USA, December 3, 2008. Protagen AG announces the closing of a cooperation contract with Bayer HealthCare AG, Leverkusen, Germany, about the evaluation of the UNIarray® technology for discovery of novel biomarkers in atrial fibrillation.
Bayer HealthCare is currently investigating atrial fibrillation after heart surgery in a clinical study. A certain number of patients develop this type of cardiac symptoms after surgery. Currently, it is not possible…
Winner Consortium “NeuroAllianz” in the BioPharma Competition counts on UNIa …
Dortmund, Germany and New Jersey, USA, October 9, 2008: Protagen AG, a leading provider of GMP compliant protein analytical services, protein bioinformatics, and protein biochips has won the BMBF’s BioPharma competition jointly with consortium “NeuroAllianz”. The twelve project partners will develop therapeutic as well as diagnostic approaches in the field of neurodegenerative diseases from bench to market under the direction of Professor Christa E. Mueller and Professor Alexander Pfeifer. Protagen…
More Releases for Charles
Interview With Charles "Chuck" George Founder of Charles George Group Interviewe …
Image: https://authoritypresswire.com/wp-content/uploads/2025/01/Chuck_George-removebg-preview.png
Charles "Chuck" George Founder of Charles George Group
Listen to the interview on the Business Innovators Radio Network: Interview With Charles "Chuck" George Founder of Charles George Group [https://businessinnovatorsradio.com/interview-with-charles-chuck-george-founder-of-charles-george-group/]
Mike Saunders welcomes Charles "Chuck" George, founder of the Charles George Group. Chuck shares his journey in the financial services industry, beginning in 1995 as a door-to-door insurance agent. He discusses the evolution of his career, including the shift to virtual meetings…
Smartphone Stock Application Market to See Booming Growth | Charles Schwab, Merr …
Latest Study on Industrial Growth of Smartphone Stock Application Market 2023-2028. A detailed study accumulated to offer Latest insights about acute features of the Smartphone Stock Application market. The report contains different market predictions related to revenue size, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends…
Equity Fund Market to See Huge Growth by 2027 | American Century, BNY Mellon, Ch …
The latest study released on the Global Equity Fund Market by AMA Research evaluates market size, trend, and forecast to 2027. The Equity Fund market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key Players in…
Breanna Charles Studio rebrands itself as Charles/Banana to create transgender a …
After her return to the art and design space, and finding herself struggling to find employment after her transition. Breanna found that a disparity in the lack of creative awareness and growth was missing in her community.
[New York, October, 9, 2022]-Breanna Charles Studio, an art and design studio, owners of upcoming Charles/Banana and Basement and Stuff Retail, announce upcoming growth within the company to counteract the disparity of the transgender…
CHARLES & KEITH Summer 2016
CHARLES & KEITH SUMMER 2016 draws on a tale of one’s journey to self discovery, a delivery of self expressionism. Pushing forth the idea of self identity, a series of visual narratives portray the dialogues of one’s inner thoughts. In this issue, international style authority Kristina Bazan shares her journey in life as well as her travel stories.
Ornate embellishments have been abandoned in pursuit of a…
Charles Rutenberg Realty Adds New Agents
Charles Rutenberg Realty is continuing their success in being one of the nation's fastest-growing Real Estate Agencies with the addition of the following new Agents to the firm:
· Vinod Persad and Sanjay Persaud, formerly of Ahmad Realty, Inc.
· Robert M. Murphy, formerly of EXIT Realty Action
· …
